Status:
COMPLETED
Exercise Intervention in Patients With Metabolic Syndrome and Renal Disease: a Prospective Study
Lead Sponsor:
University of La Laguna
Collaborating Sponsors:
Fundacion Canaria Instituto de Investigacion Sanitaria de Canarias
Conditions:
Metabolic Syndrome
CKD
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
INTRODUCTION: Obesity (OB) and metabolic syndrome (MetS) are risk and progression factors for chronic kidney disease (CKD). However, the effect of OB/MetS intervention with exercise on renal function ...
Eligibility Criteria
Inclusion
- age \>18 years
- CKD of diverse aetiologies
- estimated GFR ≥ 30 ml/min
- BMI ≥ 27 kg/m2 associated to MetS or diabetes mellitus (DM)
- stable renal function for at least 6 months before screening
- ability to perform exercise
Exclusion
- clinical conditions that exclude exercise therapy such as clinical instability, active infection, cancer, acute cardiovascular disease, advanced CKD, pulmonary hypertension, or limb amputations
- inability to understand the protocol
- severe psychiatric illness
- allergy to iodine
Key Trial Info
Start Date :
June 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 27 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06576518
Start Date
June 10 2021
End Date
May 27 2024
Last Update
August 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidad de La Laguna
San Cristóbal de La Laguna, Santa Cruz De Tenerife, Spain, 38320